Florenci V. Gonzalez Adelantado

Dr. Florenci V. Gonzalez Adelantado

Departament de química inorgànica i orgànica, Universitat Jaume I, Spain
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
KAKemel Arafet
Kemel Arafet
NSNatalia Serrano-Aparicio
Natalia Serrano-Aparicio
ALAlessio Lodola
Alessio Lodola
AMAdrian J. Mulholland
Adrian J. Mulholland
FAFlorenci V. Gonzalez Adelantado
Florenci V. Gonzalez Adelantado
Vicent MolinerVicent Moliner
Vicent Moliner
The SARS-CoV-2 main protease (Mpro) is essential for replication of the virus responsible for the COVID-19 pandemic, and one of the main targets for drug design. Here, we simulate the inhibition process of SARS-CoV-2 Mpro with a known Michael acceptor (peptidyl) inhibitor, N3. The free energy landscape for the mechanism of the formation of the covalent enzyme-inhibitor product is computed with QM/MM molecular dynamics methods. The simulations show a two-step mechanism, and give structures and calculated barriers in good agreement with experiment. Using these results and information from our previous investigation on the proteolysis reaction of SARS-CoV-2 Mpro, we design two new, synthetically accessible N3-analogues as potential inhibitors, in which the recognition and warhead motifs are modified. QM/MM modelling of the mechanism of inhibition of Mpro by these novel compounds indicates that both may be promising candidates as drug leads against COVID-19, one as an irreversible inhibitor and one as a potential reversible inhibitor.

14 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LALaura Agost-Beltrán
Laura Agost-Beltrán
SHSergio de la Hoz-Rodríguez
Sergio de la Hoz-Rodríguez
LBLledó Bou-Iserte
Lledó Bou-Iserte
SRSantiago Rodríguez
Santiago Rodríguez
AFAdrián Fernández-De-La-Pradilla
Adrián Fernández-De-La-Pradilla
FAFlorenci V. Gonzalez Adelantado
Florenci V. Gonzalez Adelantado
Since the outbreak of COVID-19, one of the strategies used to search for new drugs has been to find inhibitors of the main protease (Mpro) of the virus SARS-CoV-2. Initially, previously reported inhibitors of related proteases such as the main proteases of SARS-CoV and MERS-CoV were tested. A huge effort was then carried out by the scientific community to design, synthesize and test new small molecules acting as inactivators of SARS-CoV-2 Mpro. From the chemical structure view, these compounds can be classified into two main groups: one corresponds to modified peptides displaying an adequate sequence for high affinity and a reactive warhead; and the second is a diverse group including chemical compounds that do not have a peptide framework. Although a drug including a SARS-CoV-2 main protease inhibitor has already been commercialized, denoting the importance of this field, more compounds have been demonstrated to be promising potent inhibitors as potential antiviral drugs.

1 August 2002 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
MCMiguel Carda
Miguel Carda
SRSantiago Rodríguez
Santiago Rodríguez
FAFlorenci V. Gonzalez Adelantado
Florenci V. Gonzalez Adelantado
ECEncarnación Castillo
Encarnación Castillo
AVAlicia Villanueva
Alicia Villanueva
JMJ. Alberto Marco
J. Alberto Marco

3 March 2014 in Organic Letters
Verified
Journal Article
Closed access
AVAndreu Vidal-Albalat
Andreu Vidal-Albalat
SRSantiago Rodríguez
Santiago Rodríguez
FAFlorenci V. Gonzalez Adelantado
Florenci V. Gonzalez Adelantado

23 September 2016 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ALAntonio Latorre
Antonio Latorre
TSTanja Schirmeister
Tanja Schirmeister
JKJochen Kesselring
Jochen Kesselring
SJSascha Jung
Sascha Jung
PJPatrick Johé
Patrick Johé
FAFlorenci V. Gonzalez Adelantado
Florenci V. Gonzalez Adelantado

12 August 2010 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
FAFlorenci V. Gonzalez Adelantado
Florenci V. Gonzalez Adelantado
AJAmit Jain
Amit Jain
SRSantiago Rodríguez
Santiago Rodríguez
JCJosé A. Saéz Cases
José A. Saéz Cases
CVCristian Vicent
Cristian Vicent
GPGabriel Peris
Gabriel Peris